Vericel [VCEL] vs Vertex [VRTX] Detailed Stock Comparison
Vericel
NASDAQ
Loading...
Vertex
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Vericel wins in 5 metrics, Vertex wins in 12 metrics, with 0 ties. Vertex appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Vericel | Vertex | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 262.32 | 32.82 | Vertex |
| Price-to-Book Ratio | 6.04 | 7.05 | Vericel |
| Debt-to-Equity Ratio | 32.74 | 8.89 | Vertex |
| PEG Ratio | 76.51 | 25.16 | Vertex |
| EV/EBITDA | 197.71 | 24.22 | Vertex |
| Profit Margin (TTM) | 2.85% | 31.86% | Vertex |
| Operating Margin (TTM) | -3.21% | 38.93% | Vertex |
| EBITDA Margin (TTM) | N/A | 38.93% | N/A |
| Return on Equity | 2.59% | 22.77% | Vertex |
| Return on Assets (TTM) | 0.18% | 13.09% | Vertex |
| Free Cash Flow (TTM) | $-5.81M | $-978.00M | Vericel |
| 1-Year Return | -20.42% | -17.68% | Vertex |
| Price-to-Sales Ratio (TTM) | 7.44 | 10.62 | Vericel |
| Enterprise Value | $1.88B | $116.19B | Vertex |
| EV/Revenue Ratio | 7.55 | 10.18 | Vericel |
| Gross Profit Margin (TTM) | 73.71% | 86.90% | Vertex |
| Revenue per Share (TTM) | $5 | $44 | Vertex |
| Earnings per Share (Diluted) | $0.14 | $-3.83 | Vericel |
| Beta (Stock Volatility) | 1.27 | N/A | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Vericel vs Vertex Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Vericel | 0.25% | 3.46% | -8.27% | -10.67% | -38.05% | -34.40% |
| Vertex | -2.49% | -17.78% | -18.24% | -13.61% | -19.96% | -7.43% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Vericel | -20.42% | 29.01% | 136.42% | 958.02% | 18.59% | -92.04% |
| Vertex | -17.68% | 30.94% | 44.28% | 181.74% | 965.63% | 2,177.91% |
Performance & Financial Health Analysis: Vericel vs Vertex
| Metric | VCEL | VRTX |
|---|---|---|
| Market Information | ||
| Market Cap | $1.85B | $121.28B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 677,296 | 1,390,330 |
| 90 Day Avg. Volume | 592,669 | 1,229,373 |
| Last Close | $36.24 | $366.29 |
| 52 Week Range | $33.09 - $63.00 | $364.66 - $519.88 |
| % from 52W High | -42.48% | -29.54% |
| All-Time High | $1,590.00 (Sep 22, 1997) | $519.88 (Nov 04, 2024) |
| % from All-Time High | -97.72% | -29.54% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.20% | 0.12% |
| Quarterly Earnings Growth | 0.20% | 0.03% |
| Financial Health | ||
| Profit Margin (TTM) | 0.03% | 0.32% |
| Operating Margin (TTM) | -0.03% | 0.39% |
| Return on Equity (TTM) | 0.03% | 0.23% |
| Debt to Equity (MRQ) | 32.74 | 8.89 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $6.08 | $67.01 |
| Cash per Share (MRQ) | $2.32 | $24.90 |
| Operating Cash Flow (TTM) | $47.24M | $-562,900,000 |
| Levered Free Cash Flow (TTM) | $-5,594,625 | $-438,500,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Vericel vs Vertex
| Metric | VCEL | VRTX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 262.32 | 32.82 |
| Forward P/E | 76.51 | 25.16 |
| PEG Ratio | 76.51 | 25.16 |
| Price to Sales (TTM) | 7.44 | 10.62 |
| Price to Book (MRQ) | 6.04 | 7.05 |
| Market Capitalization | ||
| Market Capitalization | $1.85B | $121.28B |
| Enterprise Value | $1.88B | $116.19B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 7.55 | 10.18 |
| Enterprise to EBITDA | 197.71 | 24.22 |
| Risk & Other Metrics | ||
| Beta | 1.27 | N/A |
| Book Value per Share (MRQ) | $6.08 | $67.01 |
Financial Statements Comparison: Vericel vs Vertex
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | VCEL | VRTX |
|---|---|---|
| Revenue/Sales | $52.60M | $2.96B |
| Cost of Goods Sold | $16.33M | $407.50M |
| Gross Profit | $36.27M | $2.56B |
| Research & Development | $7.26M | $978.40M |
| Operating Income (EBIT) | $-12.79M | $1.15B |
| EBITDA | $-8.41M | $1.34B |
| Pre-Tax Income | $-11.25M | $1.28B |
| Income Tax | N/A | $250.10M |
| Net Income (Profit) | $-11.25M | $1.03B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | VCEL | VRTX |
|---|---|---|
| Cash & Equivalents | $73.49M | $4.67B |
| Total Current Assets | $197.64M | $10.01B |
| Total Current Liabilities | $39.45M | $3.78B |
| Long-Term Debt | $87.80M | $1.65B |
| Total Shareholders Equity | $295.49M | $16.50B |
| Retained Earnings | $-404.06M | $10.25B |
| Property, Plant & Equipment | $68.72M | $2.63B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | VCEL | VRTX |
|---|---|---|
| Operating Cash Flow | $12.44M | $404.90M |
| Capital Expenditures | N/A | $-40.70M |
| Free Cash Flow | $-7.61M | $778.20M |
| Debt Repayment | N/A | $-1.30M |
| Common Stock Repurchase | N/A | $-696.60M |
Short Interest & Institutional Ownership Analysis
| Metric | VCEL | VRTX |
|---|---|---|
| Shares Short | 5.35M | 4.19M |
| Short Ratio | 10.76 | 3.34 |
| Short % of Float | 0.14% | 0.02% |
| Average Daily Volume (10 Day) | 677,296 | 1,390,330 |
| Average Daily Volume (90 Day) | 592,669 | 1,229,373 |
| Shares Outstanding | 49.63M | 256.94M |
| Float Shares | 49.90M | 255.58M |
| % Held by Insiders | 0.01% | 0.00% |
| % Held by Institutions | 1.11% | 0.98% |
Dividend Analysis & Yield Comparison: Vericel vs Vertex
| Metric | VCEL | VRTX |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |